<DOC>
	<DOCNO>NCT00243204</DOCNO>
	<brief_summary>This Phase 3 study compare efficacy talabostat plus docetaxel docetaxel plus placebo patient Stage IIIB/IV NSCLC fail platinum-based chemotherapy regimen .</brief_summary>
	<brief_title>Study Talabostat + Docetaxel Versus Docetaxel Stage IIIB/IV Non-Small Cell Lung Cancer ( NSCLC ) After Failure Platinum-Based Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>INCLUSION CRITERIA : Men woman age 18 year old Histologically cytologically confirm NSCLC Recurrent , locally advanced metastatic , inoperable NSCLC ( Stage IIIB/IV ) Patients Stage IIIB NSCLC must cytologically document pleural effusion Failed relapsed receive platinumcontaining chemotherapy regimen firstline therapy advance NSCLC Measurable disease computerize tomography ( CT ) scan ECOG Performance Status 0 1 Expected survival ≥12 week Provide write informed consent EXCLUSION CRITERIA : More 2 prior chemotherapy regimen Clinically significant laboratory abnormality , specifically : Total bilirubin ≥ institutional upper limit normal ( ULN ) Serum alanine aminotransferase ( ALT ) aspartate aminotransferase ( AST ) ≥1.5 x ULN concomitant alkaline phosphatase &gt; 2.5 x ULN Serum creatinine ≥2.0mg/dL Absolute neutrophil count &lt; 1500/μL platelet &lt; 100,000/μL Untreated symptomatic brain metastasis Any malignancy within 5 year immediately prior first dose study medication exception basal cell nonmetastatic squamous cell carcinoma skin , carcinoma insitu cervix A history severe hypersensitivity drug formulate polysorbate 80 Any comorbidity condition , opinion investigator , may interfere assessment procedure protocol Patients within 28 day chemotherapy , radiation therapy , immunotherapy , investigational medication NSCLC . Pregnancy lactation . Women childbearing potential nonvasectomized men must agree use barrier method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Stage IIIb/IV non-small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>Lung Cancer</keyword>
</DOC>